We are proud sponsors of this years ISSCR Translating Discoveries event in Boston, USA. The event is taking place on the 17th - 19th November at the Boston Marriott Cambridge.
Experts in the preclinical, clinical, and regulatory phases discuss critical processes and strategies in development of PSC-derived therapies: selecting the cell line, characterizing the product and manufacturing considerations, managing the immune system, and working with regulators throughout the process.
Speaking from Cell and Gene Therapy Catapult:
Dr Jacqueline Barry
Chief Clinical Officer
Dr Anan Hoest-Ragab
Programme Manager
ISSCR
Dr Barry and Dr Hoest-Ragab will be hosting the Innovation Showcase on the 17th of November. Dr Barry will also be taking part in the panel ‘How to Accelerate with Accelerated Designations’ on the 19th.
Click here to learn more on the event - https://ct.catapult.org.uk/events/isscr-2022
Cell and Gene Therapy Catapult are also sponsoring the Innovation Showcase on the 17th of November at the event. We look forward to seeing you there!